Leaflet LEVATROP 2.5mg / ml concentrate for solution for infusion
- Product code:
- W70888001
- Quantity:
- 1
- Indicated for:
- heart failure
- Route of administration:
- infusion
- Substance:
- levosimendan (cardiotonic)
- ATC
- C01CX08 — Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Other cardiac stimulants
Levosimendan is a medication used for the treatment of acute decompensated heart failure. It acts as a calcium sensitizer, improving myocardial contractility without increasing oxygen consumption.
The medication is administered intravenously, usually as an infusion, under the supervision of a specialist. The dose is adjusted based on the patient's response and tolerance.
Side effects may include low blood pressure, headaches, nausea, or cardiac arrhythmias. In rare cases, severe allergic reactions may occur.
Levosimendan is not recommended for patients with severe hypotension, severe renal or hepatic impairment, or hypersensitivity to this medication.
The medication is administered intravenously, usually as an infusion, under the supervision of a specialist. The dose is adjusted based on the patient's response and tolerance.
Side effects may include low blood pressure, headaches, nausea, or cardiac arrhythmias. In rare cases, severe allergic reactions may occur.
Levosimendan is not recommended for patients with severe hypotension, severe renal or hepatic impairment, or hypersensitivity to this medication.
General data about LEVATROP 2.5mg / ml
- Substance:
- levosimendan
- Date of latest medicines list:
- 01-03-2025
- Product code:
- W70888001
- Concentration:
- 2.5mg / ml
- Pharmaceutical form:
- concentrate for solution for infusion
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.